- IR
Status of Dialogues With Shareholders and Investors(pdf:319 KB) 
- News
Nagase & Co.,Ltd. and Daicel Begin Collaboration on DX for Mixing and Agitation Processes in Manufacturing —Supporting Adoption of CAE by Designers with the Fluid Analysis Software Mixing Concierge™(pdf:370 KB) 
- News
Capital and Business Alliance Agreement With Craif Inc. —Acquiring Knowledge for Next-generation Business Development(pdf:251 KB) 
- News
Carbon Offset Implemented for Events Through Nagase & Co. and Andretti Formula E Sponsorship: Demonstrating “Delivering next sustainability”(pdf:1 MB) 
- News
Doutor Coffee Introducing Environmentally-friendly Packaging to Reduce Plastic Use —Creating “Sustainable Deliciousness” in the Coffee Industry with TiMELESS® Sold by Nagase & Co.(pdf:403 KB) 
- Info
Notice Regarding the Closing of the Acquisition of the SACHEM high-purity chemicals Business for Semiconductors in Asia
- Disclosure
Notice Regarding the Status of Repurchase of Own Shares(pdf:70 KB) 
- IR
The 110th Annual Shareholders’ Meeting
- News
NAGASE WAHLEE INDIA Established to Expand NAGASE Group’s Plastic Sales in India —Aiming to Capture Demand from Accelerating Business Transfer to India by Taiwanese and Chinese Companies(pdf:241 KB) 
- Disclosure
Consolidated Financial Statements for the Fiscal Year Ended March 31, 2025(pdf:2 MB) 
- News
NAGASE, Chiyoda, Fuji-Design and UCHIDA Successful Development of a Sustainable Technology to Extract Carbon Fibers from Damaged Formula E Car Parts and Reform Them into Usable Components(pdf:641 KB) 
- Disclosure
Notice Concerning Revision of Compensation for Directors and Executive Officers(pdf:320 KB) 
- Disclosure
Notice Concerning Revision of the Performance-Linked Share-Based Remuneration System for Officers(pdf:323 KB) 
- Disclosure
Notice Regarding Repurchase and Cancellation of Own Shares(pdf:251 KB) 
- Disclosure
Notice Concerning Differences Between Non-Consolidated Financial Results for the Fiscal Year Ended March 31, 2025 and the Respective Results for the Previous Fiscal Year(pdf:149 KB) 
- Disclosure
FY2024 Financial Briefing(pdf:4 MB) 
- Disclosure
[Summary]Consolidated Financial Statements for the Fiscal Year Ended March 31, 2025(pdf:1 MB) 
- News
Development, Manufacture and Sale of Diagnostic Reagents & Enzymes Nagase Diagnostics Co., Ltd. Integrated into NAGASE Group and Starts Operation in July 2025(pdf:200 KB) 
- News
Nagase and Highreso Enter Business Alliance Agreement —Accelerating DX in Manufacturing Industry by Linking MixingAgitation Analysis App with the Cloud(pdf:257 KB) 
- News
Prinova expands global presence with Aplinova acquisition